Hana Securities keeps target for CJ CheilJedang stock at KRW 370,000
Published on 10/14/2026 at 03:45 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSAnalyst target and earnings outlook
- Hana Securities kept its KRW 370,000 target for CJ CheilJedang on October 2, 2026.
- Second-quarter revenue reached KRW 7.36 trillion, up 1.70 percent year over year.
- Third-quarter operating profit was forecast at KRW 345.8 billion, down 0.20 percent year over year.
CJ CheilJedang stock (ISIN KR7097950000) had a KRW 370,000 target maintained by Hana Securities on October 2, 2026, while the house projected a mixed third-quarter operating picture. The estimate places biotechnology strength against weaker food demand and gives the stock a clear earnings test ahead of the next report.
Target holds as bio improves
According to ThePowerNews on October 2, 2026, Hana Securities kept its Buy rating and KRW 370,000 target. The source compared that target with a KRW 178,000 closing price on October 1, 2026, and reported projected 2027 operating profit growth of 16.70 percent excluding logistics.
The same report forecast third-quarter biotechnology revenue growth of 20.40 percent and biotechnology operating profit of KRW 80.0 billion. That forecast contrasts with an expected 2.00 percent decline in domestic processed-food revenue and a 3.00 percent increase in overseas processed-food revenue, making the division mix central to the earnings story.
Revenue grows but profit remains uneven
CJ CheilJedang reported second-quarter 2026 revenue of KRW 7.36 trillion, up 1.70 percent year over year, and operating profit of KRW 257.6 billion, according to ATS View. Net income was negative KRW 13.5 billion in the same quarter, compared with positive net income of KRW 81.8 billion in the first quarter of 2026.
The comparison shows why the analyst view depends on a recovery in biotechnology pricing rather than revenue growth alone. The latest quarterly operating margin was 3.50 percent, versus 3.30 percent in the first quarter, while the second-quarter result still included a net loss.
Next report date is November 16
A financial calendar cited by TradingView identifies November 16, 2026, as the next earnings date. The upcoming release will show whether the projected biotechnology recovery offsets food-sector pressure and the lower third-quarter operating-profit outlook.
KRW quote on the Korea Exchange
CJ CheilJedang was last at KRW 182,500 on the Korea Exchange KOSPI market on October 14, 2026 at 10:24 a.m. KST. The quote is below the KRW 270,000 52-week high and above the KRW 172,600 52-week low, both dated October 14, 2026.
The company operates across packaged foods and biotechnology, including processed foods, culinary ingredients, amino acids and animal feed. The contrast between the latest net loss and the projected biotechnology recovery leaves the next earnings report as the main test for the current analyst valuation.
CJ CheilJedang stock facts
- Company: CJ CheilJedang Corporation
- ISIN: KR7097950000
- Ticker: 097950
- Primary exchange: Korea Exchange KOSPI
- Primary exchange price: KRW 182,500 as of October 14, 2026 at 10:24 a.m. KST
- 52-week range: KRW 172,600-KRW 270,000 as of October 14, 2026
- Sector / Industry: Consumer Defensive / Packaged Foods
- Next earnings date: November 16, 2026
Market context: Market report KOSPI.
